Almac is investing $4m in broadening its biocatalysis R&D expertise. The company said the investment "will be used primarily to focus around discovery of new biocatalytic platforms that can be rapidly implemented and scaled delivering cost effective processes to chiral intermediates".
Almac
Tuesday 12 October 2010
Almac invests in biocatalysis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment